Efficacy of Ceftazidime and Cefepime in the Management of COVID-19 Patients: Single Center Report from Egypt
The purpose of this study was to explore the value of using cefepime and ceftazidime in treating patients with COVID-19. A total of 370 (162 males) patients, with RT-PCR-confirmed cases of COVID-19, were included in the study. Out of them, 260 patients were treated with cefepime or ceftazidime, with...
Guardado en:
Autores principales: | Ragaey A. Eid, Marwa O. Elgendy, Ahmed O. El-Gendy, Sara O. Elgendy, Lassaad Belbahri, Ahmed M. Sayed, Mostafa E. Rateb |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/615e678e05074b5392fbb8235de5f5f0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Effectiveness in Activating M-Type K<sup>+</sup> Current Produced by Solifenacin ([(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate): Independent of Its Antimuscarinic Action
por: Hsin-Yen Cho, et al.
Publicado: (2021) -
Comparison of Three CD3-Specific Separation Methods Leading to Labeled and Label-Free T Cells
por: Ronald Weiss, et al.
Publicado: (2021) -
Electromagnetic Interference Shielding of 2D Transition Metal Carbide (MXene)/Metal Ion Composites
por: Xuefeng Xia, et al.
Publicado: (2021) -
Neutropenia asociada al uso de cefepime en pacientes pediátricos con fibrosis quística
por: Hernández,Rubén, et al.
Publicado: (2019) -
A Rapid and Simple Multiparameter Assay to Quantify Spike-Specific CD4 and CD8 T Cells after SARS-CoV-2 Vaccination: A Preliminary Report
por: Mojtaba Shekarkar Azgomi, et al.
Publicado: (2021)